3RD ESO-ESMO-RCE PRECEPTORSHIPS & CLINICAL UPDATE ON RARE ADULT SOLID CANCERS - 1-3 DECEMBER 2018 MILAN, ITALY - AIOCC
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
3RD ESO-ESMO-RCE 1-3 December 2018
PRECEPTORSHIPS & Milan, Italy
ClINICAl UPDATE Chairs:
J.Y. Blay, FR
ON RARE ADUlT P.G. Casali, IT
SOlID CANCERS R. Stahel, CH
Held in collaboration with In the framework of
COURSES AND SEMINARS
INTRODUCTION Rare adult solid cancers account for as many as 15% of all new cancer cases, thus being the main group within rare cancers in general. This Course is aimed at dealing with them on an annual basis with the ultimate goal to strengthen the educational coverage of a group of cancers which may be neglected in spite of their collective incidence. This course has been conceived in the context of the European Reference Network on Rare Adult Solid Cancers (EURACAN) and the Joint Action on Rare Cancers of the European Union (JARC). The Faculty has been largely selected from EURACAN, also with the aim of letting this educational effort closely interact with the networking activities of EURACAN and the networking educational efforts that are ongoing within EURACAN, JARC and Rare Cancers Europe. The RARECARE project provided a definition and a list of rare cancers, the following being the 10 “families” of rare adult solid cancers: • Rare skin cancers & non-cutaneous melanoma • Rare thoracic tumors • Rare female genital cancers • Neuroendocrine tumors • Endocrine gland tumors • Sarcomas • Digestive rare cancers • Rare urological and male genital tumors • Central nervous system neoplasms • Head & neck cancers fORMAT The third edition of this joint initiative, which involves ESO, ESMO and Rare Cancers Europe, will combine: • Day 1 - Parallel Preceptorships on the majority of rare adult solid cancers. Participants will be invited to select 3 preceptorships they would like to attend. • Day 2 and 3 - Clinical updates on the main innovations from the 10 families of rare adult solid cancers. Preceptorships have been conceived by looking at at the educational needs of clinical oncologists willing to open up to rare adult solid cancers as well as patient advocates. They will be multidisciplinary and clinically oriented. The Clinical update sessions are designed to address the needs of oncologists wanting to catch up with the advancements in the treatment of rare adult solid cancers. Attendees may select whether to attend all three days or only the 2-day Clinical Update.
INVITED fACUlTY M. Angi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT S. Bielack, Klinikum Stuttgart Olgahospital, Stuttgart, DE J.Y. Blay, Centre Léon Bérard, Lyon, FR A. Berruti, ASST Spedali Civili, Brescia, IT J. Capdevila, Vall d'Hebron University Hospital, Barcelona, ES P.g. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT f. De Braud, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT A.P. Dei Tos, Azienda ULSS9, Treviso, IT f. De lorenzo, European Cancer Patient Coalition, Brussels, BE M. Deraco, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT N. fazio, Istituto Europeo di Oncologia, Milan, IT M. garassino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT N. girard, Hopital Louis Pradel, Bron, FR J.A. gietema, University Medical Center, Groningen, NL R. glynne-Jones, Mount Vernon Centre for Cancer Treatment, London, UK C. grau, Aarhus University Hospital, Aarhus, DK A. gronchi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT C. lebbé, Hopital St. Louis, Paris, FR l. licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT D. lorusso, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT V. Mazzaferro, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT K. Newbold, The Royal Marsden NHS Foundation Trust, London, UK N. Nicolai, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT U. Pastorino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT f. Peccatori, European School of Oncology, Milan, IT f. Raspagliesi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT I. Ray-Coquard, Centre Léon Bérard, Lyon, FR J. Sacco, The Clatterbridge Cancer Centre, Liverpool, UK M. Seckl, Hammersmith Campus, London, UK C. Simon, Université de Lausanne, CHUV Lausanne, CH R. Soffietti, AOU San Giovanni Battista, Torino, IT S. Stacchiotti, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT R.A. Stahel, Cancer Center University Hospital, Zurich, CH D. Talbot, Oxford University Hospital, Oxford, UK A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT M. Van den Bent, Erasmus MC Cancer Institute, Rotterdam, NL M. wartenberg, Sarcoma Patients EuroNet, Wölfersheim, DE
PROgRAMME
PRECEPTORSHIPS ON RARE ADULT SOLID CANCERS
Saturday, 1 December 2018
8:30 Registration and coffee entry
8:50 Welcome P.G. Casali, IT
INTRODUCTION (plenary)
9:00 Epidemiology and rare cancer networking A. Trama, IT
9:30 The pathologic diagnosis A.P. Dei Tos, IT
10:00 Clinical decision making in RC P.G. Casali, IT
Coffee break
PARALLEL SESSIONS
BREAKOUT PRECEPTORSHIP 1 (11:00 - 13:00)
11:00 Sarcomas S. Bielack, GR - J.Y. Blay, FR
P.G. Casali, IT - A. Gronchi, IT
11:00 Rare urogenital cancers J.A. Gietema, NL - N. Nicolai, IT
11:00 Digestive rare cancers V. Mazzaferro, IT - F. De Braud, IT
R. Glynne-Jones, UK
Lunch
BREAKOUT PRECEPTORSHIP 2 (14:00 - 16:00)
14:00 Rare female genital cancers D. Lorusso, IT - I. Ray-Coquard, FR
F. Raspagliesi, IT - M. Seckl, UK
14:00 Rare thoracic cancers R.A. Stahel, CH - M. Garassino, IT
N. Girard, FR - U. Pastorino, IT
14:00 Rare skin tumors and uveal melanoma C. Lebbé, FR - L. Licitra, IT
M. Angi, IT - J. Sacco, UK
Coffee break
BREAKOUT PRECEPTORSHIP 3 (16:30 - 18:30)
16:30 CNS tumors R. Soffietti, IT - M. van den Bent, NL
16:30 Neuroendocrine tumors D. Talbot, UK - V. Mazzaferro, IT
16:30 Head and neck cancers w/ Thyroid cancer K. Newbold, UK - J. Capdevila, ES
C. Simon, CH
CLINICAL UPDATE ON RARE ADULT SOLID CANCERS Sunday, 2 December 2018 8:30 Registration 9:00 Welcome from ESO and ESMO F. Peccatori IT - R.A. Stahel, CH UPDATE ON RARE THORACIC CANCERS Moderators: M. Garassino IT - R.A. Stahel CH 9:10 Mesothelioma R.A. Stahel, CH 9:30 Thymic tumors N. Girard, FR 9:50 Discussion UPDATE ON NEUROENDOCRINE TUMORS Moderators: D. Talbot, UK - F. De Braud IT 10:10 Thoracic neuroendocrine tumors D. Talbot, UK 10:30 Gastroenteropancreatic neuroendocrine tumors N. Fazio, IT 10:50 Discussion 11:10 Coffee break UPDATE ON DIgESTIVE RARE CANCERS Moderators: R. Labianca, IT - V. Mazzaferro, IT 11:40 Biliary tumors F. de Braud, IT 12:00 Anal carcinoma R. Glynne-Jones, UK 12:20 Peritoneal mesothelioma & pseudomyxoma peritonei M. Deraco, IT 12:40 Discussion 13:00 Lunch UPDATE ON CNS TUMORS Moderators: R. Soffietti, IT - M. van den Bent, NL 14:00 Gliomas R. Soffietti, IT 14:20 Rare CNS tumors M. van den Bent, NL 14:40 Discussion UPDATE ON SARCOMAS Moderators: P.G. Casali, IT - A. Gronchi, IT 15:00 Adult soft tissue sarcomas P.G. Casali, IT 15:20 GIST J.Y. Blay, FR 15:40 Ewing sarcoma and Osteosarcoma S. Bielack, DE 16:00 Rare bone sarcomas S. Stacchiotti, IT 16:20 Discussion 16:30 Coffee break
UPDATE ON RARE UROgENITAl CANCERS Moderators: J.A. Gietema, NL - N. Nicolai, IT 17:00 Testicular cancer J.A. Gietema, NL 17:20 Discussion UPDATE ON RARE fEMAlE gENITAl CANCERS Moderators: D. Lorusso, IT - F. Peccatori, IT 17:30 Non-epithelial ovarian tumors I. Ray-Coquard, FR 17:50 Trophoblastic tumors M. Seckl, UK 18:10 Discussion Monday, 3 December 2018 UPDATE ON RARE SKIN TUMORS & UVEAl MElANOMA Moderators: M. Angi, IT - C. Lebbé, FR 9:00 Uveal melanoma M. Angi, IT 9:20 Merkel cell carcinoma C. Lebbé, FR 9:40 Discussion UPDATE ON HEAD & NECK CANCERS Moderators: C. Grau, DK - L. Licitra, IT 10:00 Laryngeal & hypopharyngeal carcinoma L. Licitra, IT 10:20 Oropharyngeal carcinoma C. Grau, DK 10:40 Coffee break 11:00 Nasopharyngeal carcinoma & sinonasal cancers L. Licitra, IT 11:20 Salivary gland tumors L. Licitra, IT 11:40 Discussion UPDATE ON ENDOCRINE glAND TUMORS Moderator: L. Licitra, IT 12:00 Adrenal cancer A. Berruti, IT 12:20 Thyroid cancer J. Capdevila, ES 12:40 Discussion 13:00 Lunch RARE CANCERS IN EUROPE Moderators: P.G. Casali IT - F. De Lorenzo IT - M. Wartenberg DE 14:00 Session to be decided 15:30 Closing remarks, with a view to networking… P.G. Casali, IT
gENERAl INfORMATION
ORgANISINg SECRETARIAT
European School of Oncology
Rare Tumours Programme
c/o Fondazione IRCCS Istituto Nazionale dei Tumori
Via G. Venezian, 1
20133 Milan - Italy
Fax +39 0223902531 - www.eso.net
Email: raretumours@eso.net
VENUE
Fondazione Cariplo Conference Center
Via Romagnosi, 8
Milan, Italy
REgISTRATION
Preceptorship day: participants are requested to select one preceptorship in each of
the three indicated breakout slots (form to be sent together with registration form)
PATIENT ADVOCATES will be selected by Rare Cancers Europe. For information
rarecancerseurope@esmo.org
REgISTER ONlINE AT www.ESO.NET
Early late
(by 31 October) (from 1 November)
Registration fee (full participation rate - 3 days) EUR 250
EUR 300
Club ESO and ESMO Members (full participation rate) EUR 200
Registration fee (Clinical Update - 2nd and 3rd day) EUR 200
EUR 250
Club ESO and ESMO Members (Clinical Update) EUR 160
Rates are indicated in Euro and include VAT.
Registration grants participation in all sessions, coffee breaks and lunches as indicated in the
programme.
ACCREDITATION
Application for CME recognition will be submitted to the European Accreditation Council for
Continuing Medical Education (EACCME) and to the Italian CME accreditation system.
EACCME credits are recognised by the American Medical Association towards the
Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising
Secretariat.
IMPORTANT DEADlINES
TRAVEL GRANTS: 1 October 2018
EARLY REGISTRATION: 31 October 2018
LATE REGISTRATION: from 1 November 2018
CANCEllATION Of REgISTRATION OR REPlACEMENT
Cancellation should be notified to ESO in writing. In case of cancellation without
replacement, the fee minus handling charges of EUR 100 will be refunded within two
months from notification, provided that the cancellation is received by ESO before
9 November. Communication of replacements will be possible up until 15 November.
BADgE
The badge is the only official evidence of registration and should be worn at all times
during the event.
INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation
during the Course. Participants are advised to take out their own personal and travel
insurance.
OffICIAl lANgUAgE
The official language will be English. No translation will be provided.
TRAVEl gRANTS (fOR PHYSICIANS AND fUll PARTICIPATION ONlY)
Travel grants are given for full participation (three day course) on a competitive basis thanks
to the support of Rare Cancers Europe. Priority will be given to younger candidates and
low/middle income Countries. To submit the Travel grant application please complete the
online form and upload your Curriculum vitae and motivation letter by 1st October.
All applicants will be contacted by 15th October. Those applicants who are not selected for
a grant will still be able to register with the early rate fee (deadline: 31st October).
Successful Travel Grant applicants coming from the following countries will receive:
Italy € 500 (plus free registration)
Southern and western Europe € 700 (plus free registration)
Northern, Central and Eastern Europe € 800 (plus free registration)
Other and overseas € 1000 (plus free registration)
ACKNOwlEDgEMENT
ESO wishes to express its gratitude to
fondazione Cariplo - Iniziative Patrimoniali S.p.A.
for their support in hosting the course in its premises
REGISTRATION FORM - PRECEPTORSHIPS & CLINICAL UPDATE ON RARE ADULT SOLID CANCERS, 1-3 December 2018, Milan, Italy
Please fill in this form in block capitals and send by the deadline to:
European School of Oncology | Via Turati, 29 | 20121 Milan, Italy
Marina Fregonese | Fax: +39 02 85464545 | Email: raretumours@eso.net
Participant’s details
Dr. Prof. Mr. Mrs
Family name First name
Organisation Department
Street
Zip Code Town Country
Phone Fax Mobile
e-mail
Date of birth Birth place (town and country)
Profession
Specialisation Main field
VAT number (Compulsory for self-employed persons)
Fiscal code (Italian residents only)
Are you an ESMO Member? YES NO
If YES: Membership ID: Expire date (DD/MM/YYYY):
If your invoice details are different to those above, please complete the following section:
Invoice contact details
Address
e-mail Phone
VAT number (Compulsory for companies or self-employed persons)
Fiscal code (Italian residents only)
Registration fees | Rates are indicated in Euro and include VAT.
Early Late
(by 31 October) (from 1 November)
Registration fee (full participation rate - 3 days) EUR 250 EUR 300
Club ESO Members and ESMO Members (full participation rate) EUR 200 EUR 300
Registration fee Clinical Update (2 and 3 day only)
nd rd
EUR 200 EUR 250
Club ESO Members and ESMO Members (Clinical Update) EUR 160 EUR 250
Payment details
The registration is processed when payment accompanies the form (credit card details or copy of bank transfer)
Visa/Mastercard Card Number / / /
Expiry date / CV2 code
Holder’s name: and signature
BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer):
Bank: Banca Popolare di Milano, Agenzia 24 - Milan, Italy
Account holder: European School of Oncology
Number: No. 16333
IBAN: IT96G0558401624 0000000 16333 | BIC: BPMIITMMXXX
Reference: "Rare Tumours" + your name
I authorise the European School of Oncology and any possible partner organisations in the event to use my personal data
according to what is specified in Article 13 DLGS 196, available at www.eso.net or on request at fax number +39 02 8546 4545.
Signature Date
ONLINE REGISTRATION AT WWW.ESO.NET
PRECEPTORSHIP REGISTRATION FORM
1 December 2018, Milan, Italy
Please fill in this form and send it to raretumours@eso.net
together with the registration form
Family name
First name
e-mail
Please choose ONE preceptorship for each of the following breakout slots.
Breakout 1 (01.12.2018 - h. 11:00/h. 13:00)
Sarcomas
Rare urogenital cancers
Digestive rare cancers
Breakout 2 (01.12.2018 - h. 14:00/h. 16:00)
Rare female genital cancers
Rare thoracic cancers
Rare skin tumors and uveal melanoma
Breakout 3 (01.12.2018 - h. 16:30/h. 18:30)
CNS tumors
Neuroendocrine tumors
Head and neck cancers w/ Thyroid cancerYou can also read
